Yejin Kim

665 total citations · 1 hit paper
31 papers, 373 citations indexed

About

Yejin Kim is a scholar working on Psychiatry and Mental health, Molecular Biology and Artificial Intelligence. According to data from OpenAlex, Yejin Kim has authored 31 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 9 papers in Molecular Biology and 8 papers in Artificial Intelligence. Recurrent topics in Yejin Kim's work include Computational Drug Discovery Methods (7 papers), Machine Learning in Healthcare (6 papers) and Dementia and Cognitive Impairment Research (6 papers). Yejin Kim is often cited by papers focused on Computational Drug Discovery Methods (7 papers), Machine Learning in Healthcare (6 papers) and Dementia and Cognitive Impairment Research (6 papers). Yejin Kim collaborates with scholars based in United States, South Korea and Finland. Yejin Kim's co-authors include Xiaoqian Jiang, Jing Tang, Luyao Chen, Ziyi Li, Yizhuo Wang, Shuyu Zheng, Zhao Li, Ajay Jaiswal, Ying Ding and Tianhao Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and Cancer Research.

In The Last Decade

Yejin Kim

26 papers receiving 366 citations

Hit Papers

CancerGPT for few shot drug pair synergy prediction using... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yejin Kim United States 10 127 106 89 44 36 31 373
Nicholas C. Firth United Kingdom 10 117 0.9× 115 1.1× 32 0.4× 51 1.2× 100 2.8× 15 429
Jiansheng Wu China 11 261 2.1× 156 1.5× 98 1.1× 36 0.8× 17 0.5× 39 525
Alvaro Ulloa United States 10 247 1.9× 230 2.2× 125 1.4× 64 1.5× 21 0.6× 20 740
Arvind Nongpiur India 6 59 0.5× 74 0.7× 20 0.2× 27 0.6× 17 0.5× 15 259
Xiao Gan United States 6 293 2.3× 193 1.8× 33 0.4× 174 4.0× 13 0.4× 9 720
Michele Fratello Finland 15 328 2.6× 257 2.4× 31 0.3× 95 2.2× 46 1.3× 35 719
Giovanna Maria Dimitri Italy 12 81 0.6× 51 0.5× 94 1.1× 12 0.3× 5 0.1× 42 374
Antoine Lizée United States 7 269 2.1× 145 1.4× 73 0.8× 12 0.3× 26 0.7× 8 541
Petar V. Todorov United States 7 132 1.0× 91 0.9× 18 0.2× 14 0.3× 16 0.4× 10 286
Dario Kringel Germany 12 71 0.6× 43 0.4× 60 0.7× 7 0.2× 26 0.7× 28 412

Countries citing papers authored by Yejin Kim

Since Specialization
Citations

This map shows the geographic impact of Yejin Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yejin Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yejin Kim more than expected).

Fields of papers citing papers by Yejin Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yejin Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yejin Kim. The network helps show where Yejin Kim may publish in the future.

Co-authorship network of co-authors of Yejin Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Yejin Kim. A scholar is included among the top collaborators of Yejin Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yejin Kim. Yejin Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xiaozhong, et al.. (2025). Multi agent large language models for biomedical hypothesis generation in drug combination discovery. iScience. 28(12). 113984–113984.
2.
Kim, Yejin, et al.. (2024). Prediction of Mild Cognitive Impairment Status: Pilot Study of Machine Learning Models Based on Longitudinal Data From Fitness Trackers. JMIR Formative Research. 8. e55575–e55575. 1 indexed citations
3.
Ma, Xiaotian, et al.. (2024). Clinical outcome-guided deep temporal clustering for disease progression subtyping. Journal of Biomedical Informatics. 158. 104732–104732. 1 indexed citations
4.
Tariq, Muhammad Bilal, Jaroslaw Aronowski, Yang C. Fann, et al.. (2024). An interpretable framework to identify responsive subgroups from clinical trials regarding treatment effects: Application to treatment of intracerebral hemorrhage. SHILAP Revista de lepidopterología. 3(5). e0000493–e0000493. 1 indexed citations
5.
Li, Tianhao, et al.. (2024). CancerGPT for few shot drug pair synergy prediction using large pretrained language models. npj Digital Medicine. 7(1). 40–40. 59 indexed citations breakdown →
6.
Kim, Yejin, et al.. (2023). Using artificial intelligence to learn optimal regimen plan for Alzheimer’s disease. Journal of the American Medical Informatics Association. 30(10). 1645–1656. 9 indexed citations
7.
Kim, Yejin, et al.. (2023). Deep single-cell RNA-seq data clustering with graph prototypical contrastive learning. Bioinformatics. 39(6). 17 indexed citations
9.
Kim, Yejin, Kai Zhang, Sean I. Savitz, et al.. (2022). Counterfactual analysis of differential comorbidity risk factors in Alzheimer’s disease and related dementias. SHILAP Revista de lepidopterología. 1(3). e0000018–e0000018. 4 indexed citations
10.
Zhang, Kai, et al.. (2022). Scalable Causal Structure Learning: Scoping Review of Traditional and Deep Learning Algorithms and New Opportunities in Biomedicine. JMIR Medical Informatics. 11. e38266–e38266. 7 indexed citations
11.
Chen, Luyao, et al.. (2022). Emulate randomized clinical trials using heterogeneous treatment effect estimation for personalized treatments: Methodology review and benchmark. Journal of Biomedical Informatics. 137. 104256–104256. 16 indexed citations
12.
Wang, Yinyin, Luyao Chen, Zhongming Zhao, et al.. (2021). Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence. Scientific Reports. 11(1). 23179–23179. 42 indexed citations
13.
Shams, Shayan, Yejin Kim, Ananth Annapragada, et al.. (2021). Population stratification enables modeling effects of reopening policies on mortality and hospitalization rates. Journal of Biomedical Informatics. 119. 103818–103818. 4 indexed citations
14.
Li, Ziyi, Xiaoqian Jiang, Yizhuo Wang, & Yejin Kim. (2021). Applied machine learning in Alzheimer's disease research: omics, imaging, and clinical data. Emerging Topics in Life Sciences. 5(6). 765–777. 42 indexed citations
15.
Kim, Yejin, et al.. (2020). Anticancer drug synergy prediction in understudied tissues using transfer learning. Journal of the American Medical Informatics Association. 28(1). 42–51. 61 indexed citations
16.
Zhu, Cong, et al.. (2020). A lightweight convolutional neural network for assessing an EEG risk marker for sudden unexpected death in epilepsy. BMC Medical Informatics and Decision Making. 20(S12). 329–329. 7 indexed citations
17.
Kim, Yejin, Samden Lhatoo, Guo‐Qiang Zhang, Luyao Chen, & Xiaoqian Jiang. (2020). Temporal phenotyping for transitional disease progress: An application to epilepsy and Alzheimer’s disease. Journal of Biomedical Informatics. 107. 103462–103462. 3 indexed citations
18.
Kim, Yejin, et al.. (2020). Automated detection of activity onset after postictal generalized EEG suppression. BMC Medical Informatics and Decision Making. 20(S12). 327–327. 6 indexed citations
19.
Vance, Carroll P., Yejin Kim, Guo‐Qiang Zhang, et al.. (2020). Learning to detect the onset of slow activity after a generalized tonic–clonic seizure. BMC Medical Informatics and Decision Making. 20(S12). 330–330. 3 indexed citations
20.
Kim, Yejin, Robert El‐Kareh, Jimeng Sun, Hwanjo Yu, & Xiaoqian Jiang. (2017). Discriminative and Distinct Phenotyping by Constrained Tensor Factorization. Scientific Reports. 7(1). 1114–1114. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026